{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:10:52Z","timestamp":1782864652110,"version":"3.54.5"},"publisher-location":"Dordrecht","reference-count":17,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789400766266","type":"print"},{"value":"9789400766273","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-94-007-6627-3_47","type":"book-chapter","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T09:16:00Z","timestamp":1373274960000},"page":"349-353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cancer Incidence in Pulmonary Vasculitis"],"prefix":"10.1007","author":[{"given":"Katarzyna","family":"Zycinska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Kostrzewa-Janicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Nitsch-Osuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazimierz","family":"Wardyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,30]]},"reference":[{"issue":"1","key":"47_CR00471","first-page":"11","volume":"35","author":"S Bernatsky","year":"2008","unstructured":"Bernatsky, S., Ramsey-Goldman, R., & Clarke, A. E. (2008). Malignancies and cyclophosphamide exposure in Wegener\u2019s granulomatosis. Journal of Rheumatology, 35(1), 11\u201313.","journal-title":"Journal of Rheumatology"},{"issue":"8","key":"47_CR00472","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/1381612805666230110214512","volume":"5","author":"OM Colvin","year":"1999","unstructured":"Colvin, O. M. (1999). An overview of cyclophosphamide\u2019s development and clinical application. Current Pharmaceutical Design, 5(8), 555\u2013560.","journal-title":"Current Pharmaceutical Design"},{"issue":"1","key":"47_CR00473","first-page":"100","volume":"35","author":"M Faurschou","year":"2008","unstructured":"Faurschou, M., Sorensen, I. J., Mellemkjaer, L., Loft, A. G., Thomsen, B. S., Tvede, N., & Baslund, B. (2008). Malignancies in Wegener\u2019s granulomatosis: Incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. Journal of Rheumatology, 35(1), 100\u2013105.","journal-title":"Journal of Rheumatology"},{"issue":"4","key":"47_CR00474","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/rheumatology\/kep009","volume":"48","author":"M Faurschou","year":"2009","unstructured":"Faurschou, M., Mellemkjaer, L., Sorensen, I. J., Thomsen, B. S., Dreyer, L., & Baslund, B. (2009). Cancer preceding Wegener\u2019s granulomatosis: A case\u2013control study. Rheumatology (Oxford, England), 48(4), 421\u2013424.","journal-title":"Rheumatology (Oxford, England)"},{"issue":"8","key":"47_CR00475","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1136\/ard.2010.145250","volume":"70","author":"C Heijl","year":"2011","unstructured":"Heijl, C., Harper, L., Flossmann, O., St\u00fccker, I., Scott, D. G., Watts, R. A., H\u00f6glund, P., Westman, K., Mahr, A., & European Vasculitis Study Group (EUVAS). (2011). Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: Follow-up data from European Vasculitis Study Group clinical trials. Annals of the Rheumatic Diseases, 70(8), 1415\u20131421.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"47_CR00476","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00296-004-0551-0","volume":"25","author":"M Hoff","year":"2005","unstructured":"Hoff, M., & R\u00f8devand, E. (2005). Development of multiple malignancies after immunosuppression in a patient with Wegener\u2019s granulomatosis. Rheumatology International, 25(3), 238\u2013240.","journal-title":"Rheumatology International"},{"key":"47_CR00477","unstructured":"International Classification of Disease. http:\/\/www.euro.who.int\/hfadb. Accessed 30 Oct 2012."},{"key":"47_CR00478","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ijc.10444","volume":"100","author":"A Knight","year":"2002","unstructured":"Knight, A., Ascling, J., & Ekbom, A. (2002). Cancer incidence in population-based cohort of patients with Wegener\u2019s granulomatosis. International Journal of Cancer, 100, 82\u201385.","journal-title":"International Journal of Cancer"},{"issue":"5","key":"47_CR00479","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/art.30296","volume":"63","author":"G Le Guenno","year":"2011","unstructured":"Le Guenno, G., Mahr, A., Pagnoux, C., Dhote, R., Guillevin, L., & French Vasculitis Study Group. (2011). Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides. Arthritis and Rheumatism, 63(5), 1435\u20131445.","journal-title":"Arthritis and Rheumatism"},{"issue":"7","key":"47_CR004710","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/ncprheum0822","volume":"4","author":"ES Molloy","year":"2008","unstructured":"Molloy, E. S., & Langford, C. A. (2008). Balancing efficacy and cancer risk of cyclophosphamide for patients with Wegener\u2019s granulomatosis. Nature Clinical Practice Rheumatology, 4(7), 340\u2013341.","journal-title":"Nature Clinical Practice Rheumatology"},{"issue":"12","key":"47_CR004711","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/rheumatology\/keh374","volume":"43","author":"T Pankhurst","year":"2004","unstructured":"Pankhurst, T., Savage, C. O., Gordon, C., & Harper, L. (2004). Malignancy is increased in ANCA-associated vasculitis. Rheumatology (Oxford, England), 43(12), 1532\u20131535.","journal-title":"Rheumatology (Oxford, England)"},{"key":"47_CR004712","unstructured":"Polish National Cancer Registry. http:\/\/www.euro.who.int\/hfadb. Accessed 25 Oct 2012."},{"issue":"3","key":"47_CR004713","first-page":"556","volume":"85","author":"P Sharma","year":"2011","unstructured":"Sharma, P., Sharma, S., Baltaro, R., & Hurley, J. (2011). Systemic vasculitis. American Family Physician, 85(3), 556\u2013565.","journal-title":"American Family Physician"},{"issue":"8","key":"47_CR004714","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1002\/art.30394","volume":"63","author":"F Silva","year":"2011","unstructured":"Silva, F., Seo, P., Schroeder, D. R., Stone, J. H., Merkel, P. A., Hoffman, G. S., Spiera, R., Sebastian, J. K., Davis, J. C., Jr., St Clair, E. W., Allen, N. B., McCune, W. J., Ytterberg, S. R., Specks, U., & Wegener\u2019s Granulomatosis Etanercept Trial Research Group. (2011). Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener\u2019s): Long-term followup of a multicenter longitudinal cohort. Arthritis and Rheumatism, 63(8), 2495\u20132503.","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"47_CR004715","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/art.21869","volume":"54","author":"JH Stone","year":"2006","unstructured":"Stone, J. H., Holbrook, J. T., Marriott, M. A., Tibbs, A. K., Sejismundo, L. P., Min, Y. I., Specks, U., Merkel, P. A., Spiera, R., Davis, J. C., St Clair, E. W., McCune, W. J., Ytterberg, S. R., Allen, N. B., Hoffman, G. S., & Wegener\u2019s Granulomatosis Etanercept Trial Research Group. (2006). Solid malignancies among patients in the Wegener\u2019s Granulomatosis Etanercept Trial. Arthritis and Rheumatism, 54(5), 1608\u20131618.","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"47_CR004716","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/03009740903140701","volume":"39","author":"JH Takala","year":"2010","unstructured":"Takala, J. H., Kautiainen, H., & Leirisalo-Repo, M. (2010). Survival of patients with Wegener\u2019s granulomatosis diagnosed in Finland in 1981\u20132000. Scandinavian Journal of Rheumatology, 39(1), 71\u201376.","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"47_CR004717","doi-asserted-by":"publisher","first-page":"477","DOI":"10.7326\/0003-4819-124-5-199603010-00003","volume":"124","author":"C Talar-Williams","year":"1996","unstructured":"Talar-Williams, C., Hijazi, Y. M., & Walther, M. M. (1996). Cyclophosphamide-inducted cystitis and bladder cancer in patients with Wegener\u2019s granulomatosis. Annals of Internal Medicine, 124, 477\u2013484.","journal-title":"Annals of Internal Medicine"}],"container-title":["Advances in Experimental Medicine and Biology","Neurobiology of Respiration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-007-6627-3_47","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T08:29:06Z","timestamp":1674203346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-007-6627-3_47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9789400766266","9789400766273"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-94-007-6627-3_47","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"30 May 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}